ARESP IVS: Financial statements 2019
CVR: 38362720
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
ARESP IVS (CVR 38362720) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 30 and a net result of DKK 30 compared with DKK -598 the year before. Equity in the 2019 report amounted to DKK 2,702. The solvency ratio was 22.9%.
- Revenue
- DKK 0
- Gross Profit
- DKK 30
- Profit/Loss
- DKK 30
- Equity
- DKK 2,702
- Total Assets
- DKK 11,810
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | 0 | 30 | 30 | 3 t. | - |
| 2018 | 0 | -968 | -598 | 3 t. | - |
| 2017 | 0 | -670 | -670 | 3 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
ARESP IVS has published its annual report for 2018. Revenue came to DKK 0, and the net result was DKK -598.
About ARESP IVS
ARESP IVS was a Danish company of the type Iværksætterselskab based in Tranbjerg J, founded in 2017. The company has been dissolved on 14 October 2021. The company was registered under the industry Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik. In 2020, the company reported a net result of DKK 0 compared with DKK 30 the year before. Equity in the 2020 report amounted to DKK 4,000.